Literature DB >> 6091142

Herpes simplex virus latency in isolated human neurons.

B Wigdahl, C A Smith, H M Traglia, F Rapp.   

Abstract

Herpes simplex virus is most probably maintained in the ganglion neurons of the peripheral nervous system of humans in a latent form that can reactivate to produce recurrent disease. As an approximation of this cell-virus interaction, we have constructed a herpes simplex virus latency in vitro model system using human fetus sensory neurons as the host cell. Human fetus neurons were characterized as neuronal in origin by the detection of the neuropeptide substance P and the neuron-specific plasma membrane A2B5 antigen. Virus latency was established by blocking complete expression of the virus genome by treatment of infected human neurons with a combination of human leukocyte interferon and (E)-5-(2-bromovinyl)-2'-deoxyuridine for 7 days. After removal of inhibitors, virus latency was maintained for at least 9 days. This in vitro model will provide a system to analyze, in a primary human neuron, the state of the herpes simplex virus genome during establishment and maintenance of experimental latency.

Entities:  

Mesh:

Year:  1984        PMID: 6091142      PMCID: PMC391891          DOI: 10.1073/pnas.81.19.6217

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  28 in total

1.  Acute infection of differentiated neuroblastoma cells by latency-positive and latency-negative herpes simplex virus ts mutants.

Authors:  J C Gerdes; H S Marsden; M L Cook; J G Stevens
Journal:  Virology       Date:  1979-04-30       Impact factor: 3.616

Review 2.  Latent herpes simplex virus and the nervous system,.

Authors:  J G Stevens
Journal:  Curr Top Microbiol Immunol       Date:  1975       Impact factor: 4.291

3.  Latent infection of sensory ganglia with herpes simplex virus: efficacy of immunization.

Authors:  R W Price; M A Walz; C Wohlenberg; A L Notkins
Journal:  Science       Date:  1975-05-30       Impact factor: 47.728

4.  Regulation of herpesvirus macromolecular synthesis. I. Cascade regulation of the synthesis of three groups of viral proteins.

Authors:  R W Honess; B Roizman
Journal:  J Virol       Date:  1974-07       Impact factor: 5.103

Review 5.  Infection with herpes-simplex viruses 1 and 2. II.

Authors:  A J Nahmias; B Roizman
Journal:  N Engl J Med       Date:  1973-10-04       Impact factor: 91.245

Review 6.  Infection with herpes-simplex viruses 1 and 2. 1.

Authors:  A J Nahmias; B Roizman
Journal:  N Engl J Med       Date:  1973-09-27       Impact factor: 91.245

Review 7.  Infection with herpes-simplex viruses 1 and 2. 3.

Authors:  A J Nahmias; B Roizman
Journal:  N Engl J Med       Date:  1973-10-11       Impact factor: 91.245

8.  Herpes simplex virus latency in cultured human cells following treatment with cytosine arabinoside.

Authors:  F J O'Neill; R J Goldberg; F Rapp
Journal:  J Gen Virol       Date:  1972-02       Impact factor: 3.891

9.  Recovery of herpes simplex virus from human sacral ganglions.

Authors:  J R Baringer
Journal:  N Engl J Med       Date:  1974-10-17       Impact factor: 91.245

10.  Herpesvirus infections of the human central nervous system.

Authors:  L C Olson; E L Buescher; M S Artenstein; P D Parkman
Journal:  N Engl J Med       Date:  1967-12-14       Impact factor: 91.245

View more
  15 in total

Review 1.  Experimental investigation of herpes simplex virus latency.

Authors:  E K Wagner; D C Bloom
Journal:  Clin Microbiol Rev       Date:  1997-07       Impact factor: 26.132

Review 2.  Human herpesviruses: a consideration of the latent state.

Authors:  J G Stevens
Journal:  Microbiol Rev       Date:  1989-09

Review 3.  Gene transfer into the nervous system.

Authors:  X O Breakefield; A I Geller
Journal:  Mol Neurobiol       Date:  1987       Impact factor: 5.590

4.  Activation of expression of latent Epstein-Barr herpesvirus after gene transfer with a small cloned subfragment of heterogeneous viral DNA.

Authors:  J Countryman; G Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1985-06       Impact factor: 11.205

5.  Infection of human fetal dorsal root ganglion glial cells with human immunodeficiency virus type 1 involves an entry mechanism independent of the CD4 T4A epitope.

Authors:  C Kunsch; H T Hartle; B Wigdahl
Journal:  J Virol       Date:  1989-12       Impact factor: 5.103

6.  Herpes simplex virus type 1 persistence and latency in cultured rabbit corneal epithelial cells, keratocytes, and endothelial cells.

Authors:  S D Cook; S M Brown
Journal:  Br J Ophthalmol       Date:  1986-09       Impact factor: 4.638

7.  Prolonged herpes simplex virus latency in vitro after treatment of infected cells with acyclovir and human leukocyte interferon.

Authors:  A C Scheck; B Wigdahl; E De Clercq; F Rapp
Journal:  Antimicrob Agents Chemother       Date:  1986-04       Impact factor: 5.191

8.  A 3-O-sulfated heparan sulfate binding peptide preferentially targets herpes simplex virus 2-infected cells.

Authors:  Mohamed M Ali; Ghadah A Karasneh; Min Jung Jarding; Vaibhav Tiwari; Deepak Shukla
Journal:  J Virol       Date:  2012-04-04       Impact factor: 5.103

9.  Efficient quiescent infection of normal human diploid fibroblasts with wild-type herpes simplex virus type 1.

Authors:  Robert McMahon; Derek Walsh
Journal:  J Virol       Date:  2008-08-13       Impact factor: 5.103

10.  Neurons versus herpes simplex virus: the innate immune interactions that contribute to a host-pathogen standoff.

Authors:  Pamela C Rosato; David A Leib
Journal:  Future Virol       Date:  2015-06       Impact factor: 1.831

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.